The government aims to utilise land from closed pharma units for healthcare and education infrastructure in Telangana, West Bengal and Uttarakhand. It has roped in NIPER, a government-owned pharmaceutical research body, to redevelop the land in Hyderabad.
There will not be any shortage of medicines in the country because of this move, Minister of State for Fertiliser Mansukh L Mandaviya said, adding the domestic pharma industry was growing at an over 12 percent per annum rate and the government has come out with several schemes to provide drugs and medical devices at affordable rates.
The management expects order book in FY16 to be driven by domestic government orders. For international business, L&T continues to solicit infrastructure and hydrocarbons orders.
It has been a year since L&T has been attempting to divest stake in its infrastructure arm IDPL. While reports suggest the company is hoping to raise over USD 500 million through a possible stake sale, the management says determining valuations of assets in this economic scenario is taking longer than expected.
A parliamentary committee has suggested revival of pharmaceutical public sector undertakings like HAL and IDPL for large scale production of affordable generic medicines to be provided to common man.
The National Highways Authority of India (NHAI) filed two case against environment ministry Supreme Court on Tuesday. Meanwhile, the Environment Ministry on its part has hit back at the NHAI over GMR terminating a highway contract
Engineering major Larsen & Toubro(L&T) plans to divest its stake in L&T Infrastructure Development Projects (IDPL) by the end of the fiscal.